Physician profile
Quentin M Orlando
NPI 1861660409
$16,070.59
in general payments reported to CMS, 2019-2025
25 companies · $4,176 in 2025
The $4,176 reported for 2025 was more than what 80% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $955 · 2020: $616 · 2021: $1,704 · 2022: $2,787 · 2023: $2,741 · 2024: $3,092 · 2025: $4,176.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,466 · Travel and Lodging: $543.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,465.61 |
| Travel and Lodging | $543.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,692.79 | 2019-2025 | Sapien 3 Ultra Resilia, Edwards Sapien 3 Transcatheter Heart Valve (Thv), Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abiomed | $3,852.24 | 2019-2025 | Impella |
| Medtronic, INC. | $3,229.10 | 2021-2025 | Resolute Onyx, Corevalve Evolut R, Symplicity G3 |
| Abbott Laboratories | $818.50 | 2021-2025 | Navitor, Mitraclip, Diamondback Coronary |
| Boston Scientific Corporation | $595.57 | 2019-2025 | General - Balloon Catheters, Innova Vascular, General - Vascular Access |
| Medtronic Vascular, INC. | $434.10 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $358.19 | 2020-2022 | |
| Shockwave Medical, INC | $345.83 | 2025 | |
| Amgen INC. | $345.70 | 2022-2025 | Repatha |
| Teleflex LLC | $286.96 | 2022-2025 | Guideliner, Manta, Pronto |
| E.R. Squibb & Sons, L.L.C. | $277.32 | 2024-2025 | Camzyos, Eliquis |
| Stryker Corporation | $221.19 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Flowtriever |
| Pfizer INC. | $155.81 | 2024-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.76 | 2019-2025 | Jardiance |
| Inari Medical, INC. | $58.05 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $54.17 | 2024-2025 | Lifevest |
| Cordis US Corp. | $50.24 | 2022-2025 | Mynx Control Venous |
| Cardiva Medical, INC. | $29.39 | 2024 | Cardiva Vascade 6/7f Vcs |
| W. L. Gore & Associates, INC. | $25.50 | 2024 | Gore Cardioform Septal Occluder |
| Bard Peripheral Vascular, INC. | $24.49 | 2020 | |
| Cardiovascular Systems INC. | $22.50 | 2019 | |
| Amarin Pharma, INC. | $19.88 | 2020 | |
| Terumo Medical Corporation | $18.14 | 2025 | Angio-Seal, Tr Band, Glidewire |
| Janssen Pharmaceuticals, INC | $14.47 | 2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $13.70 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Quentin Orlando listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.